Brenda Jarrell Speaks on Science Career Opportunities Outside Academia
 

Brenda Jarrell Speaks on Science Career Opportunities Outside Academia

Choate Speaking Engagement

 | February 7, 2009

 | Brenda Jarrell


Event:  National Symposium on the Advancement of Women in Science Crossing Borders Conference
Organization:  Women in Science at Harvard-Radcliffe
Location:  Cambridge



 

Brenda Jarrell, co-chair of the Life Sciences Group and chair of the Intellectual Poroperty Group, spoke at the National Symposium on the Advancement of Women in Science's Crossing Borders conference.  Dr. Jarrell served on the panel discussion “Entering the World of Industry and Other Non-Academic Careers” along with:

  • Elizabeth Zhang, NSAWS Co-Director
  • Mary Lynne Hedley, Chief Scientific Officer and Executive Vice President, MGI Pharma, Inc.
  • Lisan Parker, Senior Research Biologist , Merck Research Laboratories
  • Stacie Weninger, Science Grant Manager, Fidelity

The 2009 conference is the fifth of its kind, organized by Women in Science at Harvard-Radcliffe.  WISHR promotes solidarity and community among women engaged in the sciences at Harvard College, encourages discussion on women’s issues and provides resources, inspiration and encouragement to those pursuing science-related careers.

 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline